Shen DD - Search Results

1

Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.

Wang Z, Lin YS, Dickmann LJ, Poulton EJ, Eaton DL, Lampe JW, Shen DD, Davis CL, Shuhart MC, Thummel KE. Wang Z, et al. Among authors: shen dd. J Bone Miner Res. 2013 May;28(5):1101-16. doi: 10.1002/jbmr.1839. J Bone Miner Res. 2013. PMID: 23212742 Free PMC article.

2

Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo.

Poulton EJ, Levy L, Lampe JW, Shen DD, Tracy J, Shuhart MC, Thummel KE, Eaton DL. Poulton EJ, et al. Among authors: shen dd. Toxicol Appl Pharmacol. 2013 Jan 1;266(1):122-31. doi: 10.1016/j.taap.2012.10.029. Epub 2012 Nov 12. Toxicol Appl Pharmacol. 2013. PMID: 23153560 Free PMC article. Clinical Trial.

3

CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.

Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE. Zheng S, et al. Among authors: shen dd. Transplantation. 2013 Mar 27;95(6):821-7. doi: 10.1097/TP.0b013e31827e6ad9. Transplantation. 2013. PMID: 23354298 Free PMC article.

4

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.

Yeung CK, Shen DD, Thummel KE, Himmelfarb J. Yeung CK, et al. Among authors: shen dd. Kidney Int. 2014 Mar;85(3):522-8. doi: 10.1038/ki.2013.399. Epub 2013 Oct 16. Kidney Int. 2014. PMID: 24132209 Free PMC article. Review.

5

Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.

McCune JS, Risler LJ, Phillips BR, Thummel KE, Blough D, Shen DD. McCune JS, et al. Among authors: shen dd. Drug Metab Dispos. 2005 Jul;33(7):1074-81. doi: 10.1124/dmd.104.002279. Epub 2005 Apr 8. Drug Metab Dispos. 2005. PMID: 15821045

6

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.

Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD, Thummel KE. Dai Y, et al. Among authors: shen dd. Drug Metab Dispos. 2006 May;34(5):836-47. doi: 10.1124/dmd.105.008680. Epub 2006 Feb 24. Drug Metab Dispos. 2006. PMID: 16501005

7

Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.

Gibbs MA, Thummel KE, Shen DD, Kunze KL. Gibbs MA, et al. Among authors: shen dd. Drug Metab Dispos. 1999 Feb;27(2):180-7. Drug Metab Dispos. 1999. PMID: 9929500

8

Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells.

Gibbs MA, Baillie MT, Shen DD, Kunze KL, Thummel KE. Gibbs MA, et al. Among authors: shen dd. Pharm Res. 2000 Mar;17(3):299-305. doi: 10.1023/a:1007550717526. Pharm Res. 2000. PMID: 10801218

9

Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition.

Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE. Zheng S, et al. Among authors: shen dd. Clin Pharmacol Ther. 2012 Dec;92(6):737-45. doi: 10.1038/clpt.2012.175. Epub 2012 Oct 17. Clin Pharmacol Ther. 2012. PMID: 23073208 Free PMC article.

10

Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes.

Chapron B, Risler L, Phillips B, Collins C, Thummel K, Shen D. Chapron B, et al. J Pharm Pharm Sci. 2015;18(1):101-11. doi: 10.18433/j3288c. J Pharm Pharm Sci. 2015. PMID: 25877445 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters